Nuvalent, Inc.

Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectivity to overcome resistance, minimize adverse events, and drive more durable responses. Nuvalent is advancing a robust pipeline with parallel lead programs in ROS1-positive and ALK-positive NSCLC, along with multiple discovery-stage research programs. To learn more, visit www.nuvalent.com.

Kodex (kodexglobal.com)

Companies use the Kodex portal to manage workflows, communication, and secure file transfers with law enforcement and government agencies seeking information through legal process. With request verification, end-to-end encryption, full audit trails, transparency, real-time collaboration, and API integrations, Kodex is a complete case management solution for LERT and Trust and Safety teams. Each year, millions of data requests are sent from governments and law enforcement to companies who are legally required to respond. Currently, most data requests are sent through a combination of faxes, emails, and snail mail, making it difficult to manage, track, and respond to requests securely and on time